Browsing by Author Grob, Jean-Jacques

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2015Combined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaCarlino, Matteo; Long, Georgina; Chiarion-Sileni, Vanna; Cowey, C. Lance; Dummer, R; et al, Various; Gonzalez, Rene; Grob, Jean-Jacques; Lao, Christopher; Larkin, James; Schadendorf, Dirk; Smylie, Michael; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentreCombined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma, The New England Journal of Medicine, vol.373, 1, 2015,pp 23-34
2015Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trialLong, Georgina; Chiarion-Sileni, Vanna; De Braud, Filippo; et al, Various; Garbe, Claus; Gogas, Helen; Grob, Jean-Jacques; Hauschild, Axel; Jouary, Thomas; Larkin, James; Levchenko, Evgeny; Stroyakovskiy, Daniil; Central Clinical School: The Sydney Cancer CentreDabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial, The Lancet, vol.386, 9992, 2015,pp 444-451
2017Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trialLong, Georgina; Arance, Ana; Chiarion-Sileni, Vanna; Davies, Michael; Del Vecchio, M; Flaherty, Keith; Grob, Jean-Jacques; Hogg, David; Huang, Yingjie; Lebbe, Celeste; Lesimple, Thierry; Márquez-Rodas, Ivan; Meyer, Nicolas; Mookerjee, Bijoyesh P; Mortier, Laurent; Moschos, S; Robert, Caroline; Saiag, Philippe; Thomas, Luc; Zhang, Ying; Northern Clinical School: MedicineDabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial, The Lancet Oncology, vol.18, 7, 2017,pp 863-873
2016Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trialsLong, Georgina; Davies, Michael; Flaherty, Keith; Grob, Jean-Jacques; Lane, Stephen; Legenne, Philippe; Mak, Carmen; Nathan, Paul; Ribas, Antoni; Robert, Caroline; Schadendorf, D; Northern Clinical School: MedicineFactors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials, The Lancet Oncology, vol.17, 12, 2016,pp 1743-1754
2015Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanomaLong, Georgina; Amonkar, Mayur M; Bondarenko, Igor; de Braud, Filippo; et al, Various; Garbe, Claus; Gogas, Helen; Grob, Jean-Jacques; Lebbe, Celeste; Levchenko, Evgeny; Schadendorf, Dirk; Stroyakovskiy, Daniil; Central Clinical School: The Sydney Cancer CentreHealth-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma, European Journal of Cancer, vol.51, 7, 2015,pp 833-840
2017Health-related quality of life results from the phase III CheckMate 067 studyLong, Georgina; Chiarion-Sileni, Vanna; Cowey, C; et al, Various; Gonzalez, R; Grob, Jean-Jacques; Hodi, F. Stephen; Larkin, James; Rutkowski, Piotr; Schadendorf, Dirk; Wolchok, Jedd D.; Northern Clinical School: MedicineHealth-related quality of life results from the phase III CheckMate 067 study, European Journal of Cancer, vol.82, N/A, 2017,pp 80-91
2017Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaCarlino, Matteo; Long, Georgina; Chiarion-Sileni, Vanna; Cowey, C; et al, Various; Gonzalez, Rene; Grob, Jean-Jacques; Lao, Christopher; Rutkowski, Piotr; Schadendorf, Dirk; Wagstaff, John; Wolchok, Jedd D.; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicineOverall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma, New England Journal of Medicine, vol.377, 14, 2017,pp 1345-1356
2013Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic MelanomaKefford, Richard (Rick); Long, Georgina; Amaravadi, Ravi; Arya, Niki; Ascierto, Paolo; et al, Various; Grob, Jean-Jacques; Guckert, Mary; Hamid, Omid; Kim, Kevin; Lebbe, Celeste; Minor, David; O'Hagan, Anne; Ribas, Antoni; Schadendorf, D; Simeone, Ester; Wilhelm, Tabea; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentrePhase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma, Journal of Clinical Oncology, vol.31, 26, 2013,pp 3205-3211
2016Survival of patients with advanced metastatic melanoma: The impact of novel therapiesLong, Georgina; Ascierto, Paolo; et al, Various; Flaherty, Keith; Grob, Jean-Jacques; Hauschild, Axel; Larkin, James; Lorigan, Paul; McArthur, Grant A.; Rohmel, Joachim; Ugurel, Selma; Northern Clinical School: MedicineSurvival of patients with advanced metastatic melanoma: The impact of novel therapies, European Journal of Cancer, vol.53, N/A, 2016,pp 125-134
2017Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Long, Georgina; Ascierto, Paolo; et al, Various; Flaherty, Keith; Grob, Jean-Jacques; Hauschild, Axel; Larkin, James; Lorigan, Paul; McArthur, Grant A.; Rohmel, Joachim; Ugurel, Selma; Northern Clinical School: MedicineSurvival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017, European Journal of Cancer, vol.83, N/A, 2017,pp 247-257
2015Treatment algorithms in stage IV melanomaKefford, Richard (Rick); Dummer, R; Eggermont, Alexander; Espinosa, E; Gogas, Helen; Grob, Jean-Jacques; Hauschild, Axel; Martin-Algarra, Salvador; Robert, C; Rutkowski, Piotr; Schadendorf, D; Western Clinical School: Westmead Institute for Medical ResTreatment algorithms in stage IV melanoma, American Journal of Therapeutics, vol.22, 1, 2015,pp 61-67